Jane Ellen Henney (born 1947) is an American physician who was the first woman to serve as commissioner of the U.S. Food and Drug Administration.

A significant and far reaching decision by the FDA under her tenure, was the ban on supplements and natural products that contain lovastatin, effectively handing exclusivity of cholesterol lowering compounds to pharmaceutical companies.

AstraZeneca benefited directly from this decision this removed a cheap, natural product, from competing with their own statin rosuvastatin.

She was named senior vice president and provost for health affairs at the University of Cincinnati in 2003.

You can help Wikipedia by expanding it.This biography of a person who has held a non-elected position in the federal government of the United States is a stub.